EDGAR Filing Documents for 0001457612-19-000022

Form 8-K - Current report:

SEC Accession No. 0001457612-19-000022

Filing Date

2019-02-12

Accepted

2019-02-12 08:37:06

Documents

Period of Report

2019-02-11

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	gnca8k2_12x19.htm	8-K	30926
2	EXHIBIT 4.1	ex41_pre-fundedwarrant.htm	EX-4.1	102357
3	EXHIBIT 4.2	ex42_formofwarrant.htm	EX-4.2	105295
4	EXHIBIT 99.1	ex991pressrelease_2x12x19.htm	EX-99.1	10693
5		active742019504gncapr_image1.gif	GRAPHIC	1517
6		active7402454212gncaw_image1.gif	GRAPHIC	1517
7		gncanewlogonew4.jpg	GRAPHIC	11285
	Complete submission text file	0001457612-19-000022.txt		270661

Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140

Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191

GENOCEA BIOSCIENCES, INC. (Filer) CIK: 0001457612 (see all company filings)

IRS No.: 510596811 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36289 | Film No.: 19587772
SIC: 2836 Biological Products, (No Diagnostic Substances)